MK-677
MK-677 (Ibutamoren) is an orally active growth hormone secretagogue that mimics ghrelin at the GHSR receptor. It is not a peptide. It is a small-molecule oral compound that raises GH and IGF-1 indirectly by pushing the ghrelin pathway.
That makes it a good fit for the metabolic/modulator bucket rather than the peptide bucket. In practice users choose it for sleep quality, appetite, recovery, and the long-horizon GH-axis support story without injections.
MK-677 is chosen by users who want some of the GH-axis story without injections: better sleep, recovery, skin quality, and a slow body-composition push over time. The oral convenience is the main reason it survives.
- Take orally once daily, often before bed for sleep-quality bias.
- Start at 10–15 mg rather than jumping to 25 mg.
- Monitor fasting glucose if running it beyond a short experiment.
- It is non-suppressive hormonally, but that does not make it metabolically harmless.
MK-677 (ibutamoren) is a non-peptide GH secretagogue, an orally active compound that binds the ghrelin receptor (GHSR) and stimulates pulsatile growth hormone release from the pituitary. Unlike injectable GH peptides like GHRP-2, it is taken orally once daily. Unlike direct [hGH] injection, it relies on pituitary GH reserve to amplify.
Because it binds the ghrelin receptor, it carries ghrelin-like effects: pronounced appetite stimulation, increased sleep quality, and mild water retention. The appetite increase is significant, and that alone is enough to make it a poor fit for aggressive cuts even when users like the sleep benefit.
Starting too high. Running it for months without checking glucose. Calling it a peptide because it lives in the GH-secretagogue conversation when pharmacologically it is a small-molecule oral modulator.
Compared with hGH, MK-677 is cheaper and easier but less precise. Compared with injectable peptides (Ipamorelin, GHRP-2), it removes injections but also removes the more controllable pulse-style scheduling.
Water retention, sharp appetite increase, lethargy, and reduced insulin sensitivity
Numb hands and higher fasting glucose in susceptible users
fasting glucose / HbA1c
bodyweight
blood pressure
Pre-diabetes, uncontrolled appetite, or edema-prone users with weak monitoring habits
Treating it like a harmless sleep aid or GH replacement